Master Assay Development, Commercialization and Manufacturing AgreementAgreement • March 23rd, 2017 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments • Delaware
This Master Assay Development, Commercialization and Manufacturing Agreement (“Agreement”), is entered into and effective as of November 16, 2016 (the “Effective Date”), by and between QIAGEN Manchester Limited, a UK corporation having offices at Skelton House, Lloyd Street North, Manchester, UK (“QIAGEN”), and HTG Molecular Diagnostics, Inc., a Delaware corporation having offices at 3430 E. Global Loop, Tucson, AZ, U.S.A. 85706 (“HTG”). HTG and QIAGEN are herein referred to each as a “Party” and collectively as the “Parties.”
STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 23rd, 2017 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments • New York
This Stock Purchase Agreement (this “Agreement”) is made as of November 16, 2016 (the “Effective Date”), by and between HTG Molecular Diagnostics, Inc., a Delaware corporation (the “Company”), and QIAGEN North American Holdings, Inc., a California corporation (the “Purchaser”).
